✦ LIBER ✦

Depression, sleep physiology, and antidepressant drugs

✍ Scribed by Andrew Winokur; Keith A. Gary; Shannon Rodner; Carole Rae-Red; Antonio T. Fernando; Martin P. Szuba

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 109 KB
Volume: 14
Category: Article
ISSN: 1091-4269
DOI: 10.1002/da.1043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantifying subjective assessment of sle

Quantifying subjective assessment of sleep and life-quality in antidepressant-treated depressed patients

✍ Andrew G. Mayers; Johanna C. van Hooff; David S. Baldwin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Abstract This study sought to establish a method of quantifying subjective perceptions of sleep against perceptions of life‐quality and mood, using amended versions of the Pittsburgh sleep diary (PghSD) and quality of life of insomniacs (QOLI) questionnaire. Diaries and questionnaires were self‐

Antidepressants and their effect on slee

Antidepressants and their effect on sleep

✍ Andrew G. Mayers; David S. Baldwin 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract Given the relationship between sleep and depression, there is inevitably going to be an effect of antidepressants on sleep. Current evidence suggests that this effect depends on the class of antidepressant used and the dosage. The extent of variation between the effects of antidepressan

Onset of antidepressant activity: Reexam

Onset of antidepressant activity: Reexamining the structure of depression and multiple actions of drugs

✍ Martin M. Katz; Stephen H. Koslow; Alan Frazer 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

The question of when antidepressant drugs (AD) initiate significant clinical actions in depressed patients is still unsettled. Findings from early studies on whether there is a lag in the onset of therapeutic actions were in disagreement. More recent results with the selective serotonin reuptake inh

Molecular and cellular mechanisms of ant

Molecular and cellular mechanisms of antidepressant drugs

✍ Michael J. Owens 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

The mechanism of action of the antidepressants was reviewed through the summer of 1995. Antagonism of monoamine transport is the primary cellular action associated with many antidepressant medications. However, an increased synaptic concentration of monoamines is not the actual mechanism of antidepr

Impact of the novel antidepressant agome

Impact of the novel antidepressant agomelatine on disturbed sleep–wake cycles in depressed patients

✍ Maria-Antonia Quera-Salva; Patrick Lemoine; Christian Guilleminault 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Abstract ## Background Disturbance of sleep–wake cycles is common in major depressive disorder (MDD), usually as insomnia, but also as hypersomnia or reduced daytime alertness. Agomelatine, an MT~1~ and MT~2~ receptor agonist and 5‐HT~2C~ receptor antagonist, represents a novel approach in MDD,

Assessing subjective sleep reports in th

Assessing subjective sleep reports in the first-degree relatives of antidepressant-treated depressed outpatients

✍ Andrew G. Mayers; Johanna C. van Hooff; David S. Baldwin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

## Abstract This study sought to investigate whether first‐degree relatives of depressed patients report, and react to, sleep perceptions in the same way as the depressed group. Our previous research suggested that depressed individuals may experience greater sleep ‘distress’ than healthy individua